OncoMed Pharmaceuticals, Inc. To Present At The 9th Annual JMP Securities Healthcare Conference

REDWOOD CITY, Calif., June 19, 2014 (GLOBE NEWSWIRE) -- OncoMed Pharmaceuticals, Inc. (Nasdaq:OMED), a clinical-stage company developing novel therapeutics that target cancer stem cells (CSCs), or tumor-initiating cells, today announced that Sunil Patel, Chief Financial Officer, Senior Vice President, Corporate Development and Finance of OncoMed, will present an overview of the company at the 9th Annual JMP Securities Healthcare Conference being held in New York City.

Help employers find you! Check out all the jobs and post your resume.